IP Library › Granted Patent US 10,912,750
Granted Patent B2
US 10,912,750 · App. 15/962,123 · Granted Feb 9, 2021

Modulators of Sestrin-GATOR2 interaction and uses thereof

Inventors: Eddine Saiah (Brookline, MA); George Vlasuk (Concord, MA)
Assignee: NAVITOR PHARMACEUTICALS, INC.
A61K31/198A61K31/145A61K31/69A61P25/24A61P25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,912,750
App. No.
15/962,123
Granted
Feb 9, 2021
Kind
B2
Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Claims (6)

1. A method of treating treatment-resistant depression in a patient in need thereof, said method comprising administering to said patient a compound of formula I-90 or pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable composition thereof:

2. The method according to claim 1 , wherein said method further comprises administering to said patient an additional therapeutic agent or therapy.

3. The method of claim 1 , wherein the pharmaceutically acceptable composition comprising a compound of formula I-90 further comprises a pharmaceutically acceptable carrier, adjuvant, or vehicle.

4. The method according to claim 3 , wherein said method further comprises administering to said patient an additional therapeutic agent or therapy.

5. The method according to claim 1 , wherein the treatment-resistant depression is resistant to first line treatments.

6. The method according to claim 1 , wherein the treatment-resistant depression is resistant to second line treatments.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 6, 2026
From: NAVITOR PHARMACEUTICALS, INC.
To: SUPERNUS PHARMACEUTICALS, INC.
Reel/Frame 075552/0122 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2018
From: SAIAH, EDDINE; VLASUK, GEORGE
To: NAVITOR PHARMACEUTICALS, INC.
Reel/Frame 045708/0001 →
Continuity (2)
Provisional Application 62490280 · Apr 26, 2017
Related Publication 20180333381A1 · Nov 22, 2018
Cited By (4)
US 12,252,456 US 12,378,263 US 12,427,130 US 12,465,583